XANAX

500 Microgram Tablets

Pfizer Healthcare IrelandPA0822/141/003

Main Information

Trade NameXANAX
Active SubstancesALPRAZOLAM
Strength500 Microgram
Dosage FormTablets
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/141/003

Group Information

ATC CodeN05BA12 Benzodiazepine derivatives

Status

Authorised/WithdrawnAuthorised
Licence Issued27/04/2012
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing StatusMarketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceThis product contains a substance listed in schedule 4, part 1 to the Misuse of Drugs Regulations 2017.

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0094-040-002
Interchangeable List DocumentPDF of Interchangeable List
« Back

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.